Xenetic Biosciences (NASDAQ: XBIO)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Xenetic Biosciences (NASDAQ: XBIO) through any online brokerage.
The latest price target for Xenetic Biosciences (NASDAQ: XBIO) was reported by HC Wainwright & Co. on Monday, May 2, 2022. The analyst firm set a price target for 4.00 expecting XBIO to rise to within 12 months (a possible 487.80% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Xenetic Biosciences (NASDAQ: XBIO) is $0.6805 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for Xenetic Biosciences.
Xenetic Biosciences’s Q2 earnings are confirmed for Friday, August 12, 2022.
There is no upcoming split for Xenetic Biosciences.
Xenetic Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.